Register
Register
Register

Project cooperationUpdated on 16 January 2026

Cognitive AI for decision support and multi-objective optimization

CEO INNOVACOG at INNOVACOG

SIX-FOURS, France

About

We are seeking a consortium in need of a technology partner capable of producing and integrating intelligible predictive models (more effective than only explainable) to facilitate decision-making and/or the search for optimal solutions. Model intelligibility is essential for prescriptive systems in medicine.

We use augmented cognitive AI (XTRACTIS) that produces intelligible (transparent) predictive models through the discovery of logical rules (knowledge).

XTRACTIS induces rules from structured data (biomarkers, epigenomes, ...). For image and temporal signal modalities, it is necessary to first extract the features relevant to the domain expert (preprocessing).

XTRACTIS can meet the requirements of the EU AI ​​Act for high-risk systems.

Another fundamental characteristic of this approach is the ability to invert models to search for solutions (drug formulation, prescription) through multi-objective optimization.

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
  • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
  • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
  • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
  • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
  • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

INNOVACOG

Start-up

SIX-FOURS, France

Similar opportunities

  • Project cooperation

    SME biotech partner offering integrated genomic and epigenomic profiling for early cancer prediction

    • Offering Expertise to Consortias
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Ana Pou

    Project Manager at Aniling

    Barcelona, Spain

  • Project cooperation

    PanGI Landmark Graph™ – Whole-Tract Capsule Intelligence

    • Offering Expertise to Consortias
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Miadreza Shafiekhah

    Head of Research and Innovation at Nowocert

    Dublin, Ireland

  • Project cooperation

    CortexView Imaging Intelligence™ – AI-Enhanced Acquisition and Diagnosis

    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Miadreza Shafiekhah

    Head of Research and Innovation at Nowocert

    Dublin, Ireland